According to many observers we are standing on the precipice

Clinical trials are not cheap to conduct, and with data integrity

We all get them, some of us more than 10 a day, emails from journals

There is a short summary of a scientific paper called an abstract

Occasionally, a manuscript will be accepted on first submission without revisions.

We have just released our latest Frailomic consortium

Phenotype-specific omic expression patterns in people with frailty could provid

Welcome to the second issue of the Refractory Asthma Stratification

Titles are the first thing readers see, yet often they are addressed

The UK's world-class human challenge study gives us new information about SARS-CoV-2 cases that were mild in 36 healthy.

The scientific literature comprises scholarly publications that report original

Our publication on the potential benefits of bariatric surgery

Welcome to the Frailomic Newsletter Update for 2016.

ive years ago I was lucky enough to be involved in a project that resulted in publications

At some point, you'll want to share your great projects with your friends

The last 20 years at Niche have been amazingly exciting – offering

Metathesiophobia: from Preclinical to Clinical Development

Metathesiophobia: from Preclinical to Clinical Development

One notable characteristic of Brexit has been a race for the bottom by journalists

There are people everywhere who use two spaces after a full-stop.

However you may feel about the way political leaders have turned Brexit

Metathesiophobia: from Preclinical to Clinical Development

Experience at Niche has taught us that clinical study protocols are born in the white-hot fire

Welcome to the latest issue of the Refractory Asthma Stratification Programme (RASP-UK)

In its recent white paper on severe asthma, The Severe Asthma Report 2017

The Institute for Apprenticeships (IFA) has approved its 300th

Metathesiophobia: from Preclinical to Clinical Development

The comparison of the DPP4 (dipeptidyl peptidase 4) SARS-CoV-2

Visit our brand-new website to learn more about our innovative training programme

Welcome to the latest edition of the Frailomic Initiative Newsletter.

Metathesiophobia: from Preclinical to Clinical Development

sA lot of people say that people don't just buy things, they buy connection

The proceedings of the Association for Human Pharmacology in the Pharmaceutical Industry (AHPPI)

Writing your PhD thesis can be a once-in-a-lifetime opportunity

Our group of academic and industry partners won a big MRC grant yesterday

If you're managing a project, it's important to stay informed about work progress

This essential reading provides readers with a round-up of news on the latest events

Epidemiological data suggest that at two in five of us will experience

People working in the sciences aren’t generally perceived as being outgoing.

The sudden imposition of remote working in response to the 2020 COVID-19

When a country’s economy becomes so dominated by a single export industry

Last week was the 20-year anniversary of my founding Niche Science & Technology Ltd.

There are many regulatory documents but perhaps none are more critical

The first publication to come out of our UK Refractory Asthma

Finding the best vehicle in which to publish your research findings is a perennial challenge.

Metathesiophobia: from Preclinical to Clinical Development

We use the term coming of age to describe the transition into adulthood

All of our core studies have now completed their clinical phase

Download the third issue of the Refractory Asthma Stratification

Creating an awesome title is like bending a straight line into a circle.

I'm sure that everyone works hard and tries to do their best.

Early in 2020, COVID-19 was spreading rapidly across the globe.

The world's first human COVID challenge trial has been given the green light

The largest pharmaceutical companies not surprisingly rely on the largest contract research organizations

Posters are an excellent opportunity to showcase your work

Want a conversation to warm your heart and lift your spirits

We have some strange terms in the pharma industry

We all have a responsibility to encourage young people to study science

The latest issue of Journal Frontiers in Pharmacology has just published

May 4 is often known as ‘Star Wars Day’. It is jokingly said

It was encouraging to see so many partners at the 2017 General Assembly meeting last December

Because new biologic treatments for asthma can be expensive and cause side effects,

At the start of the year many of us faced changes to the way we work as the COVID-19

Yesterday was 20 years since the Memorandum

Clinical consensus statements are agreed opinions formulated by a group of experts

Our team are exploring different and novel ways for young people to enter the pharmaceutical industry.

Never judge a book by its cover –we know

Today my son has taken his GCSE exam in Critical Thinking.

In this case the plan is a paradigm shift in the way we will manage

We wanted to tell you about our latest Insider’s Insight - Ta dah

Attend any research meeting, conference or clinical congress

Last week marked 12 months since I was involved in a life-changing accident.

The EUropean Federation for Exploratory MEdicines Development (EUFEMED

You may think that 'writing the abstract' simply  involves summarising

In the past, Halloween has meant the end of the crop and the start of the dark, cold winter.

Asthma is a chronic inflammatory disorder of the airways

The world's first human COVID challenge trial has been given the green light

Phase I is the lifeblood or new medicines. The UK’s Phase I representative body,

RASP-UK underwent its third progress review by the MRC on 19 May.

In response to my post with tips for people who want to start their own business

Music has a remarkable ability to bring people together and permeate

I am continually reminded that I must work toward better relationships with my sons than the one I had with my dad.

The EUropean Federation for Exploratory MEdicines Development (EUFEMED

The world's first human COVID challenge trial has been given the green light

A new guidance document for the publication of company-sponsored

There have been hundreds of thousands of deaths from COVID-19

Metathesiophobia: from Preclinical to Clinical Development

Read the latest newsletter from both our MID-Frail

Welcome everyone to the first issue of the Frailomic consortium

Know the difference between an eye-catching, action-inspiring poster

Concerns about readiness of the European Medicines Agency’s (EMA) Clinical Trials Information System persist as the.

Work never stops and after the findings of our ground breaking survey in the EMWA

You can waste a considerable amount of time when reviewing and editing

On this day 2 years ago I had a pretty bad accident getting knocked off my motorbike

Deep Breath is the official newsletter of the UKs Refactory Asthma

We all need heroes - people who can champion our cause - helping the world to understand our rationale

Do you know what Good Laboratory Practice stands for? In nonclinical animal studies

As a jobbing scientist you rarely spend your whole career working on the same project.

Since 2013 we have been sharing our understanding on key issues with friends and clients via our Insider’s Insights.

Scientific knowledge should be accessible to all and if you are those communicating science